jueves, 31 de enero de 2019

How realistic is an ‘off-the-shelf’ CAR-T drug? - STAT

How realistic is an ‘off-the-shelf’ CAR-T drug? - STAT
Daily Recap


STAT Plus: These pricey new cancer therapies are custom-made. Can they ever be more mainstream?

By IKE SWETLITZ


ELAINE THOMPSON/AP
Right now, pricey CAR-T cancer therapies are custom-made for each patient. Making a version that anyone could use could take years.

No hay comentarios:

Publicar un comentario